Pernix Sleep, Inc. Contracts & Agreements

AGREEMENT AND PLAN OF MERGER BY AND AMONG PERNIX THERAPEUTICS HOLDINGS, INC., PERNIX ACQUISITION CORP. I AND SOMAXON PHARMACEUTICALS, INC. DATED ASOF DECEMBER 10, 2012 TABLE OF... (Filed With SEC on December 11, 2012)

AMENDMENT NO. 3 TO MANUFACTURING SERVICES AGREEMENT (Filed With SEC on September 14, 2012)

OFFICE LEASE AGREEMENT BETWEEN SB CORPORATE CENTRE III-IV, LLC, AS LANDLORD AND SOMAXON PHARMACEUTICALS, INC. AS TENANT TABLE OF CONTENTS (Filed With SEC on August 29, 2012)

LEASE TERMINATION AGREEMENT (Filed With SEC on August 29, 2012)

SOMAXON PHARMACEUTICALS, INC. 9,422,496 shares of Common Stock and Warrants to purchase up to 4,711,248 shares of Common Stock PLACEMENT AGENT AGREEMENT (Filed With SEC on July 20, 2012)

SOMAXON PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on July 20, 2012)

[To be separately provided to the Investor] (Filed With SEC on July 20, 2012)

SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on July 19, 2012)

MANUFACTURING SERVICES AGREEMENT (Filed With SEC on July 19, 2012)

SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on July 19, 2012)

LICENSE AGREEMENT DATED AS OF APRIL 26, 2012 BY AND BETWEEN SOMAXON PHARMACEUTICALS, INC. AND CJCHEILJEDANG CORPORATION LICENSE AGREEMENT (Filed With SEC on May 17, 2012)

LICENSE AGREEMENT DATED AS OF APRIL 26, 2012 BY AND BETWEEN SOMAXON PHARMACEUTICALS, INC. AND CJCHEILJEDANG CORPORATION LICENSE AGREEMENT (Filed With SEC on May 2, 2012)

SUPPLY AGREEMENT (Filed With SEC on May 2, 2012)

WARRANT TO PURCHASE STOCK (Filed With SEC on March 9, 2012)

2012 Incentive Plan Somaxon Pharmaceuticals, Inc. (Filed With SEC on February 27, 2012)

Sincerely, /s/ Richard W. Pascoe Richard W. Pascoe President and Chief Executive Officer (Filed With SEC on November 25, 2011)

EX-101 INSTANCE DOCUMENT (Filed With SEC on November 4, 2011)

Signed: /s/ Jeffrey D. Weedman Name: Jeffrey D. Weedman Title: Vice President, Global Business Development (Filed With SEC on October 3, 2011)

SOMAXON PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on October 3, 2011)

WARRANT TO PURCHASE STOCK Company: Somaxon Pharmaceuticals, Inc., a Delaware corporation Number of Shares: 194,384, as may be adjusted from time to time hereafterin accordance... (Filed With SEC on August 2, 2011)

WARRANT TO PURCHASE STOCK Company: Somaxon Pharmaceuticals, Inc., a Delaware corporation Number of Shares: 233,261, as may beadjusted from time to time hereafterin accordance with... (Filed With SEC on August 2, 2011)

WARRANT TO PURCHASE STOCK Company: Somaxon Pharmaceuticals, Inc., a Delaware corporation Number of Shares: 155,507, as may be adjusted from time to time hereafterin accordance... (Filed With SEC on August 2, 2011)

SOMAXON PHARMACEUTICALS, INC. Common Stock ($0.0001 par value per share) AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT (Filed With SEC on August 2, 2011)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 2, 2011)

LICENSE AGREEMENT DATED AS OF JUNE 7, 2011 BY AND BETWEEN SOMAXON PHARMACEUTICALS, INC. AND PALADIN LABS INC. (Filed With SEC on June 13, 2011)

SUPPLY AGREEMENT (Filed With SEC on June 13, 2011)

PURCHASE AGREEMENT (Filed With SEC on June 13, 2011)

OFFICE LEASE (Filed With SEC on May 25, 2011)

2011 Incentive Plan (Filed With SEC on February 14, 2011)

Supplement One (Filed With SEC on February 11, 2011)

SOMAXON PHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on February 8, 2011)

LIBOR/Prime Referenced Rate Addendum To Loan and Security Agreement (Filed With SEC on February 8, 2011)

8,800,000 Shares SOMAXON PHARMACEUTICALS, INC. Common Stock ($0.0001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on November 24, 2010)

Current assets (Filed With SEC on November 10, 2010)

CO-PROMOTION AGREEMENT (Filed With SEC on August 25, 2010)

Publicis Touchpoint Solutions, Inc. 2000 Lenox Drive, Suite 100 Lawrenceville, NJ 08648 Tel: 609 ###-###-#### Fax: 609 ###-###-#### PROFESSIONAL DETAILING SERVICES AGREEMENT (Filed With SEC on July 21, 2010)

Supplement One (Filed With SEC on July 21, 2010)

LEASE AGREEMENT (Filed With SEC on April 28, 2010)

SOMAXON PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 14, 2010)

2010 Incentive Plan (Filed With SEC on April 7, 2010)

6,000,000 Shares (Filed With SEC on March 31, 2010)

Maximize the value of Silenor. Silenor was approved by the FDA for the treatment of insomnia characterized by difficulty with sleep maintenance in March 2010. We believe that... (Filed With SEC on March 19, 2010)

Current assets (Filed With SEC on August 7, 2009)

Number of Options (Filed With SEC on July 21, 2009)

WARRANT NO. 2009-WarrantNumber NUMBER OF SHARES: Number_of_Shares DATE OF ISSUANCE: July 8, 2009 (subject to adjustment hereunder) WARRANT TO PURCHASE SHARES OF COMMON STOCK OF (Filed With SEC on July 8, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 8, 2009)

Current assets (Filed With SEC on May 8, 2009)

Exhibit Number (Filed With SEC on April 24, 2009)

Maximize the value of Silenor. We have successfully completed our four Phase 3 clinical trials for Silenor in the treatment of insomnia. We designed our Phase 3 clinical program... (Filed With SEC on March 13, 2009)

Results of Operations and Financial Condition (Filed With SEC on August 7, 2008)

WARRANT TO PURCHASE STOCK (Filed With SEC on May 22, 2008)

WARRANT (Filed With SEC on May 22, 2008)

LOAN AND SECURITY AGREEMENT (Filed With SEC on May 22, 2008)

COMMON STOCK PURCHASE AGREEMENT by and between KINGSBRIDGE CAPITAL LIMITED and SOMAXON PHARMACEUTICALS, INC. dated as of May 21, 2008 (Filed With SEC on May 22, 2008)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 22, 2008)

in a clinical trial to evaluate SILENORtm in the treatment of adults (229) with chronic insomnia in a sleep laboratory setting, SILENORtm demonstrated a statistically significant... (Filed With SEC on March 12, 2008)

Amount of Bonus (Filed With SEC on February 25, 2008)

SOMAXON PHARMACEUTICALS, INC. (Filed With SEC on April 3, 2007)

Amount of Bonus (Filed With SEC on March 7, 2007)

SOMAXON PHARMACEUTICALS, INC. (Filed With SEC on January 29, 2007)

W I T N E S S E T H: (Filed With SEC on November 14, 2006)

Exhibit No (Filed With SEC on June 28, 2006)

SOMAXON PHARMACEUTICALS, INC. (Filed With SEC on May 16, 2006)

Current assets (Filed With SEC on May 11, 2006)

SILENOR tm for Insomnia. According to the American Psychiatric Association, approximately one-third of adult Americans (approximately 73 million people) are affected by insomnia.... (Filed With SEC on March 22, 2006)

Amount of Bonus (Filed With SEC on March 8, 2006)

SILENOR for Insomnia. According to the American Psychiatric Association, approximately one-third of adult Americans (approximately 73 million people) are affected by insomnia. One... (Filed With SEC on December 13, 2005)

SILENOR for Insomnia. According to the American Psychiatric Association, approximately one-third of adult Americans (approximately 73 million people) are affected by insomnia. One... (Filed With SEC on November 30, 2005)

SILENOR for Insomnia. According to the American Psychiatric Association, approximately one-third of adult Americans (approximately 73 million people) are affected by insomnia. One... (Filed With SEC on November 23, 2005)

SILENOR for Insomnia. According to the American Psychiatric Association, approximately one-third of adult Americans (approximately 73 million people) are affected by insomnia. One... (Filed With SEC on October 7, 2005)

Category

Industry

Companies

Contracts

Pernix Sleep, Inc. Contracts & Agreements